| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |